Warn Patients Not to Rely on OTC Primatene Mist for Asthma

Primatene Mist (epinephrine) will return to OTC shelves for relieving mild symptoms of intermittent asthma in patients age 12 and up.

It was withdrawn in 2011 due to chlorofluorocarbon (CFC) propellant regulations, NOT safety issues. But most of us were happy to see it go.

Now Primatene Mist is back with an HFA propellant.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote